基于磁共振成像的影像组学与深度学习模型预测胶质瘤表皮生长因子受体状态:系统综述与Meta分析
该系统综述与Meta分析检索多个数据库,纳入12项评估胶质瘤EGFR扩增的研究,其中6项进入Meta分析。影像组学模型汇总敏感度0.74、特异度0.88、AUC 0.87;亚洲研究汇总特异度显著高于北美研究。作者认为影像组学可能有助于无创预测EGFR扩增并辅助分层。
要点
- 影像组学模型预测胶质瘤EGFR扩增的汇总敏感度0.74、特异度0.88、AUC 0.87。
- 亚洲研究的汇总特异度显著高于北美研究。
- 深层学习模型未给出汇总估计,仅影像组学模型有合并数值。
核心结论
- 影像组学可能具有预测胶质瘤患者EGFR扩增的潜力,有助于改善预后评估与治疗计划。
- 这些模型可能促进针对EGFR靶向治疗的无创患者分层,可能改善临床决策并减少高风险活检的需求。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Scopus、Embase和Web of Science。
- 共纳入12项评估EGFR扩增的研究进入系统综述,其中6项纳入Meta分析。
- 研究质量采用METhodological RadiomICs Score(METRICS)工具评估。
- 采用双变量模型计算汇总敏感度、特异度、阳性似然比(DLR+)、阴性似然比(DLR-)、诊断比值比(DOR)和曲线下面积(AUC)。
诊断标准与关键数值
- 影像组学模型预测EGFR扩增的汇总敏感度为0.74。
- 影像组学模型预测EGFR扩增的汇总特异度为0.88。
- 影像组学模型汇总DLR+为6.12、DLR-为0.29、DOR为21.07、AUC为0.87。
- 亚洲研究的汇总特异度显著高于北美研究。
- Deek's漏斗图不对称检验未检测到显著发表偏倚,敏感性分析未发现离群值。
临床应用与阅片要点
- 原文结论指出影像组学可能用于无创预测胶质瘤EGFR扩增并辅助患者分层。
- 原文未据此给出具体的阅片流程或报告建议。
局限性
- 原文结论使用「可能」表述影像组学的潜力,并指出这些模型可能减少高风险活检的需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Epidermal growth factor receptor (EGFR) alterations are associated with prognosis in glioma patients. We systematically reviewed the performance of radiomics and deep learning (DL) models in predicting EGFR alterations and provided pooled estimates for the former.
MATERIAL AND METHODS: A comprehensive search was performed across PubMed, Scopus, Embase, and Web of Science. Study quality was assessed using the METhodological RadiomICs Score (METRICS) tool. A bivariate model was used to compute pooled estimates of sensitivity, specificity, positive likelihood ratio (DLR+), negative likelihood ratio (DLR-), diagnostic odds ratio (DOR), and area under the curve (AUC). A subgroup analysis was carried out to explore potential sources of heterogeneity. To detect potential outliers, bivariate boxplot and sensitivity analyses were performed. Deek's funnel plot asymmetry test was utilised to evaluate the publication bias.
RESULTS: A total of 12 studies assessing EGFR amplification were included in the systematic review, with six incorporated into the meta-analysis. The pooled results of the radiomics models were as follows: sensitivity: 0.74; specificity: 0.88; DLR+: 6.12; DLR-: 0.29; DOR: 21.07; and AUC: 0.87. A significantly higher pooled specificity was observed among studies conducted in Asia than among those performed in North America. No significant publication bias was detected, and the sensitivity analysis did not identify any outliers.
CONCLUSION: Radiomics may have potential in predicting EGFR amplification in glioma patients, improving prognostic assessments and treatment planning. These models may facilitate noninvasive patient stratification for EGFR-targeted therapies, potentially improving clinical decision-making and reducing the need for high-risk biopsies.
引用
- Ahmadzadeh AM, Ashoobi MA, Broomand Lomer N, et al. Magnetic resonance imaging (MRI)-derived radiomics and deep learning models for predicting epidermal growth factor receptor status in glioma: a systematic review and meta-analysis. Clin Radiol. 2025. PMID: 40974758. doi:10.1016/j.crad.2025.107049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。